Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person17
Biomea Fusion, Inc.
Company
American Fusion, Inc.
Company
BiomX Inc.
Company
BIOMERICA INC
Company
Valion Bio, Inc.
Company
INTRUSION INC
Company
BirchBioMed Inc.
Company
Nuvation Bio Inc.
Company
Advanced Biomed Inc.
Company
BIOGEN INC.
Company
BIOVIE INC.
Company
Beta Bionics, Inc.
Company
BEL FUSE INC /NJ
Company
GRI Bio, Inc.
Company
Q32 Bio Inc.
Company
BioAtla, Inc.
Company
IMPACT BIOMEDICAL INC.
Company
Primary record3
Biomea Fusion, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure On October 13, 2026, Biomea Fusion, Inc. (the Company ) hosted a conference call and live webcast to discuss topline data for its ongoing Phase 1 GLP-131 clinical trial for BMF-650. The
Biomea Fusion, Inc. filed 8-K
Item 8.01. Other Events. On September 22, 2026, Biomea Fusion, Inc. (the Company ) updated the anticipated timing for topline results from the Company s ongoing Phase I GLP-131 trial for BMF-650 in obese, otherwise healt
Biomea Fusion, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 5, 2026, Biomea Fusion, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026. The full text of the press rele